| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,804 | 2,842 | 08:40 | |
| 2,800 | 2,846 | 08:41 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 20,000 | 400 | |||
| 12,800 | 375 | |||
| 12,500 | 455 | |||
| 9,900 | 100 | |||
| 5,500 | 2.000 | |||
| 5,100 | 200 | |||
| 2,870 | 474 | |||
| 2,866 | 474 | |||
| 2,862 | 948 | |||
| 2,826 | 6.180 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/ayj.htm [/URL] | ||||
| 6.180 | 2,800 | |||
| 948 | 2,762 | |||
| 474 | 2,758 | |||
| 474 | 2,754 | |||
| 200 | 2,600 | |||
| 1.000 | 0,037 | |||
| 1.068 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 10.344 | 1,122 | 11.606 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 16:48:42 | 2,810 | 304 |
| 16:10:30 | 2,822 | 30 |
| 15:44:29 | 2,820 | 7.740 |
| 15:44:29 | 2,820 | 1.200 |
| 15:32:52 | 2,844 | 30 |
| 14:59:28 | 2,824 | 249 |
| 14:59:28 | 2,822 | 651 |
| 13:40:12 | 2,790 | 6 |
| 13:40:12 | 2,790 | 4 |
| 13:25:35 | 2,776 | 6 |
| 13:08:48 | 2,766 | 197 |
| 13:08:48 | 2,766 | 1.114 |
| 13:08:48 | 2,764 | 886 |
| 13:08:48 | 2,766 | 2.000 |
| 13:05:34 | 2,780 | 1.091 |
| 13:05:34 | 2,774 | 451 |
| 12:45:06 | 2,800 | 1.947 |
| 12:45:06 | 2,800 | 1.895 |
| 12:45:04 | 2,800 | 800 |
| 12:45:04 | 2,800 | 11.842 |
| Tagesumsatz Xetra | - | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Valneva SE - 6-K, Report of foreign issuer | 31 | SEC Filings | ||
| Do | Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC | 30 | GlobeNewswire (USA) | ||
| VALNEVA Aktie jetzt für 0€ handeln | |||||
| Do | Valneva-Aktie im freien Fall - was das jetzt für Ihre Geldanlage bedeutet | Hebelschein-Spekulant | |||
| Mi | VALNEVA SE - Eilmeldung am Abend: Bewegung im Schatten! | 84 | Maximilian Berger | ||
| Mi | Oil Volatility Shakes Markets - Life Sciences Stocks Back in Focus: Bayer, Vidac Pharma, Valneva, Novo Nordisk, and Pfizer | 60 | The Market Herald Canada |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 | ACCESS Newswire | - Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome -- Dermata plans to launch its first DTC product, our Foundational... ► Artikel lesen | |
| Do | ViroGates A/S: ViroGates announces its Annual Report 2025: Revenue growth and improved operating result as strategic transition towards preventive health and longevity continues | GlobeNewswire (Europe) | Company Announcement no. 1/2026 (March 26, 2026 at 15:10:00 CET)
Inside information
BIRKERØD, DENMARK ViroGates A/S ("ViroGates" or "Company"), a medical technology company developing blood tests for... ► Artikel lesen | |
| 01:06 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen Announces FDA IND Clearance for Partner NEOK Bio's NEOK002 Targeting Solid Tumors | Business Wire | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.03.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 26.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.03.2026.ISIN NameCA2568277834 DOLLY... ► Artikel lesen | |
| Do | NurExone stellt Weichen für Wachstum und Sichtbarkeit | Small- & Micro Cap Investment |